Synergistic Effects of Atorvastatin and Sildenafil in Cardioprotection—Role of NO Rakesh C. Kukreja Editorial 09 March 2006 Pages: 5 - 8
Drug Safety in Cardiovascular Disease: A Call to ACTION John J. V. McMurray Editorial 14 March 2006 Pages: 9 - 10
ACE-Inhibition for Secondary Prevention of Cardiovascular Events—Should We Change Our Recommendation After PEACE? Roberto Ferrari Editorial 23 March 2006 Pages: 11 - 12
Inhibition of Myocardial Apoptosis by Ischaemic and Beta-Adrenergic Preconditioning is Dependent on p38 MAPK Johannes A. MoolmanShahiem HartleyAmanda Lochner Basic Pharmacology 14 March 2006 Pages: 13 - 25
Enhanced Cardioprotection Against Ischemia-Reperfusion Injury with Combining Sildenafil with Low-Dose Atorvastatin Salvatore RosanioYumei YeYochai Birnbaum Basic Pharmacology 23 January 2006 Pages: 27 - 36
Correlation Between Inflammation and Oxidative Stress in Normocholesterolemic Coronary Artery Disease Patients ‘on’ and ‘off’ Atorvastatin for Short Time Intervals M. K. ThomasD. NarangS. K. Maulik Clinical Pharmacology and Drug Studies 09 March 2006 Pages: 37 - 44
Safety of Nifedipine GITS in Stable Angina: The ACTION Trial Philip A. Poole-WilsonBridget-Anne Kirwanon behalf of the ACTION Investigators Clinical Trial 14 March 2006 Pages: 45 - 54
Prognosis at 6 Months for Coronary and Cerebrovascular Patients: Impact of Antiplatelet Agents and Statins: Results from the Prevenir III Study Jean FerrièresJean-Pierre CambouLouis Guize Clinical Trial 14 March 2006 Pages: 55 - 61
Safety and Long-Term Efficacy of Sirolimus Eluting Stent in ST-elevation Acute Myocardial Infarction: The REAL (Registro REgionale AngiopLastiche Emilia-Romagna) Registry Gianfranco PercocoAntonio Manarifor the Real Investigators Clinical Trials 09 March 2006 Pages: 63 - 68
The Current Role of ACE-inhibitors for Secondary Prevention in Cardiovascular Disease; from Pathogenesis to Clinical Practice Adriaan A. VoorsDirk J. van VeldhuisenWiek H. van Gilst Review Pages: 69 - 73